Medicilon Logo
search icon search icon language icon contact icon menu icon
Medicilon Logo
search icon close search icon language icon contact icon menu icon
Contact Us
Close Button
Back To Top
Online Message×
Click switch
Close Button
Medicilon's News information
News information

Visiting Medicilon at SOT 62nd Annual Meeting and ToxExpo

Page View:

SOT1.pngWe are pleased to announce that Medicilon will exhibit in the SOT 2023 with the Booth #1307. The conference starts from March 19-23 at Nashville Music City, in downtown Nashville, TN.

Medicilon team will be present throughout the conference. In addition, our VP Dr. Renzong Xie (Toxicology Research) and Dr. Jing Deng (Pharmacology, PD & Biology) will also participate the event. Please stop by at our booth and discuss how Medicilon’s services and capabilities could support your research needs and expedite your drug discovery and development process.

About SOT 2023

The SOT 62nd Annual Meeting and ToxExpo will feature more than 70 Featured and Scientific Sessions, 2,000 presentations, 250 exhibitors, and 5,000 attendees. The Featured and Scientific Sessions will also take place alongside 2,000+ poster presentations. The atmosphere during the SOT Annual Meeting and ToxExpo is relaxed, yet lively, with attendees dressed in business casual attire. The science is taken seriously, but presenters and registrants are friendly and approachable. This is an in-person event only and there will be no live online or virtual element of the meeting.

Toxicology Services in Medicilon

Medicilon specializes in preclinical toxicology. Our worldwide clients benefit from a full range of safety assessment services that range from rapid lead optimization through fully GLP-compliant toxicology studies. With more than 1,000 experts, we offer you the broadest and deepest bench of professionals in the industry.


•     Mice

•     Rats

•     Guinea Pigs

•     Rabbits

•     Beagles

Administration Routes

•     Implant

•     Inhalation

•     Intradermal

•     Intramuscular

•     Intraperitoneal

•     Intravenous

•     Rectal

•     Subcutaneous

•     Vaginal

Safety Pharmacology Studies in Medicilon

Safety pharmacology evaluations are an essential step in assessing acute and potentially life-threatening risks of novel pharmaceuticals as part of an IND-enabling program. Experts in Medicilon dedicate time to assist in the mitigation of risk by evaluating programs in the discovery/lead optimization phase, which will ultimately save time in the preclinical phase of development.

Fully Capable Core Battery of Studies

•     Central Nervous System (CNS)

•     Respiratory System

•     Cardiovascular System

•     Drug R&D

Drug Types

•     Small molecule Drugs

•     Biotech Based Drugs

•     Vaccines

•     Traditional Chinese Medicine

#SOT2023 #Toxicology #Preclinical #Drug Safety Evaluation

Relevant newsRelevant news